FR2901703B1 - Utilisation de zatosetron pour le traitement de la rosacee, et compositions pharmaceutiques - Google Patents

Utilisation de zatosetron pour le traitement de la rosacee, et compositions pharmaceutiques

Info

Publication number
FR2901703B1
FR2901703B1 FR0651984A FR0651984A FR2901703B1 FR 2901703 B1 FR2901703 B1 FR 2901703B1 FR 0651984 A FR0651984 A FR 0651984A FR 0651984 A FR0651984 A FR 0651984A FR 2901703 B1 FR2901703 B1 FR 2901703B1
Authority
FR
France
Prior art keywords
zatosetron
rosacea
treatment
pharmaceutical compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0651984A
Other languages
English (en)
Other versions
FR2901703A1 (fr
Inventor
Jean Dominique Pierret
Fabrizio Folfi
Christian Loesche
Nadege Tremel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR0651984A priority Critical patent/FR2901703B1/fr
Priority to PCT/FR2007/051361 priority patent/WO2007138233A2/fr
Publication of FR2901703A1 publication Critical patent/FR2901703A1/fr
Application granted granted Critical
Publication of FR2901703B1 publication Critical patent/FR2901703B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0651984A 2006-05-31 2006-05-31 Utilisation de zatosetron pour le traitement de la rosacee, et compositions pharmaceutiques Expired - Fee Related FR2901703B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0651984A FR2901703B1 (fr) 2006-05-31 2006-05-31 Utilisation de zatosetron pour le traitement de la rosacee, et compositions pharmaceutiques
PCT/FR2007/051361 WO2007138233A2 (fr) 2006-05-31 2007-05-31 Utilisation du zatosetron pour le traitement de la rosacee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0651984A FR2901703B1 (fr) 2006-05-31 2006-05-31 Utilisation de zatosetron pour le traitement de la rosacee, et compositions pharmaceutiques

Publications (2)

Publication Number Publication Date
FR2901703A1 FR2901703A1 (fr) 2007-12-07
FR2901703B1 true FR2901703B1 (fr) 2012-12-07

Family

ID=37663114

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0651984A Expired - Fee Related FR2901703B1 (fr) 2006-05-31 2006-05-31 Utilisation de zatosetron pour le traitement de la rosacee, et compositions pharmaceutiques

Country Status (2)

Country Link
FR (1) FR2901703B1 (fr)
WO (1) WO2007138233A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2942138A1 (fr) * 2009-02-16 2010-08-20 Galderma Res & Dev Association de composes pour le traitement ou la prevention des affections dermatologiques
MX2012000572A (es) 2009-07-14 2012-05-08 Albany Molecular Res Inc Moduladores del receptor 5-hidroxi triptamina 3 (5-ht3), metodos para su realización y uso de los mismos.
FR2960152A1 (fr) * 2010-01-27 2011-11-25 Galderma Res & Dev Utilisation de modulateur de recepteurs a l'histamine de type 2 pour le traitement de la rosacee et composition les contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA886585B (en) * 1987-09-08 1990-05-30 Lilly Co Eli Specific 5-ht,antagonists
EP1600158A1 (fr) * 2004-05-26 2005-11-30 Galderma Research & Development, S.N.C. Compositions pharmaceutiques contenant de l'ondansetron et son utilisation pour le traitement de l'inflammation

Also Published As

Publication number Publication date
FR2901703A1 (fr) 2007-12-07
WO2007138233A3 (fr) 2008-01-24
WO2007138233A2 (fr) 2007-12-06

Similar Documents

Publication Publication Date Title
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
FR14C0050I1 (fr) Compositions et leurs utilisations pour le traitement de la sclerose en plaques
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
CL2013001654A1 (es) Compuestos derivados de 6-amino-2-fenilamino-1h-bencimidazol-5-carboxamida; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de las enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2008001002A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2007003523A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
BRPI0807907A2 (pt) co-cristais e composições farmacêuticas compreendendo os mesmos.
FR2925339B1 (fr) Medicament pour le traitement du cancer du pancreas
FR2887450B1 (fr) Ingredient concentre pour le traitement et/ou la modification de surfaces, et son utilisation dans des compositions cosmetiques
BRPI0814957A2 (pt) Composto, pró-droga, agente farmacêutico, método para a profilaxia ou tratamento de uma doença, distúrbio ou condição, e, uso do composto.
CL2007002920A1 (es) Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
FR2900819B1 (fr) Compose de type bis-uree, composition le comprenant, utilisation et procede de traitement cosmetique
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
BRPI1009781A2 (pt) compostos para o tratamento de distúrbios metabólicos, composição farmacêutica que os compreende e uso dos mesmos
FR2910325B1 (fr) Utilisation de lupulones pour la prevention et la therapie du cancer colorectal.
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
FR21C1049I2 (fr) Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
EP2056857A4 (fr) Compositions pharmaceutiques comprenant ccl2 et leur utilisation dans le traitement d'une inflammation
CL2007000850A1 (es) Compuestos derivados de benzimidazol; procedimiento de preparacion; composicion farmaceutica; y uso para prevenir o tratar condiciones de huesos asociadas con la reduccion fuerte o resorcion incrementada de calcio.
FR2897533B1 (fr) Agent oxydant pour le traitement des cheveux

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140131